Papua New Guinea vs Senegal: Reported versus estimated cases of polio
Papua New Guinea
0 cases
in 2023
Senegal
0 cases
in 2023
Papua New Guinea rank
26th
Senegal rank
26th
Reported versus estimated cases of polio over time
- Papua New Guinea
- Senegal
How they compare
Papua New Guinea currently reports 0 cases against 0 cases in Senegal, a difference of 0 cases.
The two have swapped places 4 times across 44 shared years of data; in 1980 it was Senegal ahead.
Papua New Guinea ranks 26th and Senegal ranks 26th of 199 countries.
Across the 5 decades both report, Papua New Guinea averaged higher in 1 and Senegal in 3.
Head to head by decade
| Decade | Papua New Guinea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 15.6 cases | 123.1 cases | 107.5 cases | Senegal |
| 1990s | 1.1 cases | 4.1 cases | 3 cases | Senegal |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 2.6 cases | 1.8 cases | 0.8 cases | Papua New Guinea |
| 2020s | 0 cases | 3.5 cases | 3.5 cases | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported versus estimated cases of polio, Papua New Guinea or Senegal?
- Papua New Guinea, at 0 cases against 0 cases in Senegal as of 2023.
- What is the difference in reported versus estimated cases of polio between Papua New Guinea and Senegal?
- 0 cases, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Senegal?
- 44 years are reported by both, from 1980 to 2023.
- How do Papua New Guinea and Senegal rank globally for reported versus estimated cases of polio?
- Papua New Guinea ranks 26th and Senegal ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported versus estimated cases of polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.